Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-11
2006-04-11
Barts, Samuel (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S085000, C546S146000, C546S147000, C546S150000, C548S146000, C548S452000, C548S494000, C548S495000, C548S567000, C548S569000, C548S566000, C544S402000
Reexamination Certificate
active
07026485
ABSTRACT:
N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
REFERENCES:
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover et al.
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Hoover et al.
patent: H725 (1990-01-01), Gordon
patent: 4963530 (1990-10-01), Hemmie et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5643924 (1997-07-01), Talley et al.
patent: 5648364 (1997-07-01), Talley et al.
patent: 5756534 (1998-05-01), Talley et al.
patent: 5948790 (1999-09-01), Talley et al.
patent: 6180646 (2001-01-01), Talley et al.
patent: 6506759 (2003-01-01), Talley et al.
patent: 6762187 (2004-07-01), Talley et al.
patent: 79823 (1988-04-01), None
patent: 104 041 (1984-03-01), None
patent: 114 993 (1984-08-01), None
patent: 264795 (1986-10-01), None
patent: 223437 (1987-05-01), None
patent: 337714 (1989-10-01), None
patent: 342541 (1989-11-01), None
patent: 346 847 (1989-12-01), None
patent: 356223 (1990-02-01), None
patent: 389898 (1990-10-01), None
patent: 393445 (1990-10-01), None
patent: 393457 (1990-10-01), None
patent: 480711 (1990-10-01), None
patent: 402646 (1990-12-01), None
patent: 480624 (1992-04-01), None
patent: 480714 (1992-04-01), None
patent: 2200115 (1988-07-01), None
patent: 2209752 (1989-05-01), None
patent: WO 84/03044 (1984-01-01), None
patent: WO 92/00750 (1992-01-01), None
Drugs of the Future, 1991, 16(3), pp. 210-212.
Nature, No. 6130, Aug. 6-12, 1987, p. 482, vol. 328.
V. J. Hunby et al., Pept. Struct. Funct. Proc. Am. Pept. Sym, 8thed., 1983, pp. 511-520.
Roberts et al., Rational design of peptide-based inhibitors, Science, 248, 358 (1990).
Erickson et al., Design activity and 2.8 a crystal structure of a C2 Symmetric inhibitor Compexed to HIV-1 Protease, Science, 249, 527 (1990).
Meek et al, Ihbibition of HIV-1 protease in infected T-lymphocytes by synethetic peptide analogues, Nature, 343, 90 (1990).
McQuade et al., A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation, Science, 247, 454 (1990).
A. Sali et al., “High Resolution X-ray Diffraction Study of the Complex between Endothiapepsin and an Oligopeptide Inhibitor: The Analysis of the Inhibitor Binding and Description of the Rigid Shift in the Enzyme”, The EMBO Journal, vol. 8, No. 8, pp. 2179-2188 (Oxford, GB 1989).
Clare Michael
DeCrescenzo Gary A.
Freskos John Nicholas
Getman Daniel P.
Heintz Robert M.
Banner & Witcoff , Ltd.
Barts Samuel
G.D. Searle & Co.
LandOfFree
Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549180